Cervical Cancer Screening: Comparison of conventional Pap smear test, liquid-based cytology and human papillomavirus testing as stand-alone or co-testing strategies

HPV and Gynecologic Cancer

Modeling the balance of benefits and harms of cervical cancer screening with cytology and human papillomavirus testing

Cancer Epidemiol Biomarkers Prev.

Malagón T, Mayrand MH, Ogilvie G, Gotlieb WH, Blake J, Bouchard C, Franco EL, Kulasingam S

doi: 10.1158/1055-9965.EPI-20-0190.

HPV and Gynecologic Cancer

Benefit and burden in the Dutch cytology-based versus high-risk human papillomavirus-based cervical cancer screening program

Am J Obstet Gynecol.

Loopik DL, Koenjer LM, Siebers AG, Melchers WJG, Bekkers RLM

doi: 10.1016/j.ajog.2020.08.026.

HPV and Gynecologic Cancer

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

JAMA.

Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ

doi: 10.1001/jama.2018.7464.

HPV and Gynecologic Cancer

Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France

J Infect.

Lefeuvre C, Pivert A, Guillou-Guillemette HL, Fabiani FL, Veillon P, Banaszuk ALD, Ducancelle A

doi: 10.1016/j.jinf.2020.05.006.

HPV and Gynecologic Cancer

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program

JAMA Intern Med.

Wentzensen N, Clarke MA, Bremer R, Poitras N, Tokugawa D, Goldhoff PE, Castle PE, Schiffman M, Kingery JD, Grewal KK, Locke A, Kinney W, Lorey TS

doi: 10.1001/jamainternmed.

HPV and Gynecologic Cancer

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders

Br J Cancer.

Lam JUH, Elfström KM, Ejegod DM, Pedersen H, Rygaard C, Rebolj M, Lynge E, Juul KE, Kjær SK, Dillner J, Bonde J

doi: 10.1038/bjc.2017.371.

HPV and Gynecologic Cancer

Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement

JAMA.

US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng CW, Wong JB

doi: 10.1001/jama.2018.10897.

HPV and Gynecologic Cancer

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer

Br J Cancer.

Lagheden C, Eklund C, Lamin H, Kleppe SN, Lei J, Elfström KM, Sundström K, Andrae B, Sparén P, Dillner J

doi: 10.1038/s41416-018-0053-6.

HPV and Gynecologic Cancer

Genetic variations in human papillomavirus and cervical cancer outcomes

Int J Cancer.

Rader JS, Tsaih SW, Fullin D, Murray MW, Iden M, Zimmermann MT, Flister MJ

doi: 10.1002/ijc.32038.

Related content

Modeling the balance of benefits and harms of cervical cancer screening with cytology and human papillomavirus testing

Benefit and burden in the Dutch cytology-based versus high-risk human papillomavirus-based cervical cancer screening program

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders

Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer

Genetic variations in human papillomavirus and cervical cancer outcomes